{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:56:54Z","timestamp":1784527014048,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["2015R1A2A2A01004341"],"award-info":[{"award-number":["2015R1A2A2A01004341"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Science and ICT","award":["2017R1A5A2014768"],"award-info":[{"award-number":["2017R1A5A2014768"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jns.2018.07.011","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T21:21:05Z","timestamp":1533676865000},"page":"77-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["1-Methyl-4-phenyl-1,2,3,6 tetrahydropyridine\/probenecid impairs intestinal motility and olfaction in the early stages of Parkinson's disease in mice"],"prefix":"10.1016","volume":"392","author":[{"given":"Jin Gyu","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Gyoung","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namkwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Sook","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 11","key":"10.1016\/j.jns.2018.07.011_bb0005","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/124.11.2131","article-title":"Pathophysiology of bradykinesia in Parkinson's disease","volume":"124","author":"Berardelli","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jns.2018.07.011_bb0010","first-page":"209","article-title":"Postural instability and falls in Parkinson's disease","volume":"87","author":"Bloem","year":"2001","journal-title":"Adv. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2018.07.011_bb0015","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.jns.2018.07.011_bb0020","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.jns.2018.07.011_bb0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrneurol.2010.52","article-title":"Molecular and clinical prodrome of Parkinson disease: implications for treatment","volume":"6","author":"Schapira","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"Suppl 1","key":"10.1016\/j.jns.2018.07.011_bb0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","article-title":"Non-motor symptoms in Parkinson's disease","volume":"15","author":"Poewe","year":"2008","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2018.07.011_bb0035","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/WCO.0000000000000112","article-title":"Premotor and nonmotor features of Parkinson's disease","volume":"27","author":"Goldman","year":"2014","journal-title":"Curr. Opin. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2018.07.011_bb0040","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1212\/WNL.0b013e31829c5c86","article-title":"Evolution of mild cognitive impairment in Parkinson disease","volume":"81","author":"Broeders","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2018.07.011_bb0045","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/mds.10387","article-title":"Higher incidence of depression preceding the onset of Parkinson's disease: a register study","volume":"18","author":"Leentjens","year":"2003","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.jns.2018.07.011_bb0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/mds.25664","article-title":"Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms","volume":"29","author":"Duncan","year":"2014","journal-title":"Mov. Disord."},{"issue":"Suppl 1","key":"10.1016\/j.jns.2018.07.011_bb0055","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S1353-8020(13)70007-5","article-title":"Premotor parkinsonism models","volume":"20","author":"Bezard","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2018.07.011_bb0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2017.05.013","article-title":"The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse","volume":"105","author":"Giesert","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.jns.2018.07.011_bb0065","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1111\/j.1365-2982.2012.01974.x","article-title":"Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation","volume":"24","author":"Wang","year":"2012","journal-title":"Neurogastroenterol. Motil."},{"issue":"8","key":"10.1016\/j.jns.2018.07.011_bb0070","doi-asserted-by":"crossref","first-page":"18865","DOI":"10.3390\/ijms160818865","article-title":"Major alterations of phosphatidylcholine and Lysophosphotidylcholine lipids in the substantia Nigra using an early stage model of Parkinson's disease","volume":"16","author":"Farmer","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2018.07.011_bb0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12929-015-0166-7","article-title":"Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease","volume":"22","author":"Hernandez-Chan","year":"2015","journal-title":"J. Biomed. Sci."},{"issue":"9","key":"10.1016\/j.jns.2018.07.011_bb0080","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1007\/s12035-016-0190-y","article-title":"Transcriptome profile changes in mice with MPTP-induced early stages of Parkinson's disease","volume":"54","author":"Alieva","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.jns.2018.07.011_bb0085","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s10517-015-2990-x","article-title":"Activity of monoamine oxidase in the nigrostriatal system at Presymptomatic and early symptomatic stages of parkinsonism in mice","volume":"159","author":"Khakimova","year":"2015","journal-title":"Bull. Exp. Biol. Med."},{"issue":"2","key":"10.1016\/j.jns.2018.07.011_bb0090","first-page":"155","article-title":"Modeling early Parkinson's disease pathology with chronic low dose MPTP treatment","volume":"31","author":"Korecka","year":"2013","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.jns.2018.07.011_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jnutbio.2016.08.014","article-title":"Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing alpha-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\/probenecid model","volume":"39","author":"Gu","year":"2017","journal-title":"J. Nutr. Biochem."},{"issue":"6","key":"10.1016\/j.jns.2018.07.011_bb0100","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/jnc.12343","article-title":"Probenecid potentiates MPTP\/MPP+ toxicity by interference with cellular energy metabolism","volume":"127","author":"Alvarez-Fischer","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jns.2018.07.011_bb0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-62703-251-3_17","article-title":"The MPTP\/probenecid model of progressive Parkinson's disease","volume":"964","author":"Carta","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.jns.2018.07.011_bb0110","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00295-0","article-title":"Mouse model of parkinsonism: a comparison between subacute MPTP and chronic MPTP\/probenecid treatment","volume":"106","author":"Petroske","year":"2001","journal-title":"Neuroscience"},{"issue":"91","key":"10.1016\/j.jns.2018.07.011_bb0115","doi-asserted-by":"crossref","DOI":"10.3791\/51785-v","article-title":"Behavioral and locomotor measurements using an open field activity monitoring system for skeletal muscle diseases","author":"Tatem","year":"2014","journal-title":"J. Vis. Exp."},{"issue":"76","key":"10.1016\/j.jns.2018.07.011_bb0120","doi-asserted-by":"crossref","DOI":"10.3791\/50303-v","article-title":"Assessment of sensorimotor function in mouse models of Parkinson's disease","author":"Fleming","year":"2013","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.jns.2018.07.011_bb0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0022-3565(25)25065-0","article-title":"Centrally administered bombesin affects gastrointestinal transit and colonic bead expulsion through supraspinal mechanisms","volume":"238","author":"Koslo","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.jns.2018.07.011_bb0130","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jcmgh.2015.12.008","article-title":"Intestinal dysbiosis contributes to the delayed gastrointestinal transit in high-fat diet fed mice","volume":"2","author":"Anitha","year":"2016","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.jns.2018.07.011_bb0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1460-9568.2008.06346.x","article-title":"Olfactory deficits in mice overexpressing human wildtype alpha-synuclein","volume":"28","author":"Fleming","year":"2008","journal-title":"Eur. J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.jns.2018.07.011_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(03)00219-5","article-title":"Olfactory function in apoE knockout mice","volume":"150","author":"Nathan","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jns.2018.07.011_bb0145","series-title":"Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates 4th Edition","author":"Paxinos","year":"2012"},{"key":"10.1016\/j.jns.2018.07.011_bb0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fnsys.2013.00095","article-title":"Decomposition of abnormal free locomotor behavior in a rat model of Parkinson's disease","volume":"7","author":"Grieb","year":"2013","journal-title":"Front. Syst. Neurosci."},{"issue":"4","key":"10.1016\/j.jns.2018.07.011_bb0155","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","article-title":"In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease","volume":"47","author":"Lee","year":"2000","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2018.07.011_bb0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.57.2.205","article-title":"Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis","volume":"57","author":"Schwarz","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2018.07.011_bb0165","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.nicl.2017.03.011","article-title":"Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease","volume":"14","author":"Caminiti","year":"2017","journal-title":"Neuroimage Clin."},{"issue":"Pt 8","key":"10.1016\/j.jns.2018.07.011_bb0170","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson's disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.jns.2018.07.011_bb0175","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1523\/JNEUROSCI.4720-05.2006","article-title":"Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice","volume":"26","author":"Li","year":"2006","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.jns.2018.07.011_bb0180","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/apha.12229","article-title":"The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra","volume":"211","author":"Zheng","year":"2014","journal-title":"Acta Physiol (Oxford)"},{"issue":"2","key":"10.1016\/j.jns.2018.07.011_bb0185","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jcmgh.2016.01.003","article-title":"Intrinsic gastrointestinal macrophages: their phenotype and role in gastrointestinal motility","volume":"2","author":"Cipriani","year":"2016","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.jns.2018.07.011_bb0190","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.nbd.2012.04.009","article-title":"Alpha-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits","volume":"47","author":"Hallett","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"8","key":"10.1016\/j.jns.2018.07.011_bb0195","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/WNR.0b013e3282ffda5e","article-title":"Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein","volume":"19","author":"Wang","year":"2008","journal-title":"NeuroReport"},{"issue":"6","key":"10.1016\/j.jns.2018.07.011_bb0200","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1523\/JNEUROSCI.3982-03.2004","article-title":"Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation","volume":"24","author":"Li","year":"2004","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.jns.2018.07.011_bb0205","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/mds.22464","article-title":"Biopsies of olfactory epithelium in patients with Parkinson's disease","volume":"24","author":"Witt","year":"2009","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.jns.2018.07.011_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077509","article-title":"Olfaction in three genetic and two MPTP-induced Parkinson's disease mouse models","volume":"8","author":"Kurtenbach","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.jns.2018.07.011_bb0215","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00401-013-1144-3","article-title":"Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys","volume":"126","author":"Mundinano","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.jns.2018.07.011_bb0220","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.bbadis.2014.08.005","article-title":"Excessive microglial activation aggravates olfactory dysfunction by impeding the survival of newborn neurons in the olfactory bulb of Niemann-pick disease type C1 mice","volume":"1842","author":"Seo","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.jns.2018.07.011_bb0225","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.nbd.2011.10.019","article-title":"Neurochemistry and the non-motor aspects of PD","volume":"46","author":"Ferrer","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2018.07.011_bb0230","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fnana.2017.00046","article-title":"Early paradoxical increase of dopamine: a neurochemical study of olfactory bulb in asymptomatic and symptomatic MPTP treated monkeys","volume":"11","author":"Pifl","year":"2017","journal-title":"Front. Neuroanat."},{"issue":"1","key":"10.1016\/j.jns.2018.07.011_bb0235","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00401-011-0830-2","article-title":"Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders","volume":"122","author":"Mundinano","year":"2011","journal-title":"Acta Neuropathol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18302983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18302983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:46:05Z","timestamp":1758383165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X18302983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":47,"alternative-id":["S0022510X18302983"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2018.07.011","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1-Methyl-4-phenyl-1,2,3,6 tetrahydropyridine\/probenecid impairs intestinal motility and olfaction in the early stages of Parkinson's disease in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2018.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}